Cargando…

Fhit Delocalizes Annexin A4 from Plasma Membrane to Cytosol and Sensitizes Lung Cancer Cells to Paclitaxel

Fhit protein is lost or reduced in a large fraction of human tumors, and its restoration triggers apoptosis and suppresses tumor formation or progression in preclinical models. Here, we describe the identification of candidate Fhit-interacting proteins with cytosolic and plasma membrane localization...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaudio, Eugenio, Paduano, Francesco, Spizzo, Riccardo, Ngankeu, Apollinaire, Zanesi, Nicola, Gaspari, Marco, Ortuso, Francesco, Lovat, Francesca, Rock, Jonathan, Hill, Grace A., Kaou, Mohamed, Cuda, Giovanni, Aqeilan, Rami I., Alcaro, Stefano, Croce, Carlo M., Trapasso, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819369/
https://www.ncbi.nlm.nih.gov/pubmed/24223161
http://dx.doi.org/10.1371/journal.pone.0078610
Descripción
Sumario:Fhit protein is lost or reduced in a large fraction of human tumors, and its restoration triggers apoptosis and suppresses tumor formation or progression in preclinical models. Here, we describe the identification of candidate Fhit-interacting proteins with cytosolic and plasma membrane localization. Among these, Annexin 4 (ANXA4) was validated by co-immunoprecipitation and confocal microscopy as a partner of this novel Fhit protein complex. Here we report that overexpression of Fhit prevents Annexin A4 translocation from cytosol to plasma membrane in A549 lung cancer cells treated with paclitaxel. Moreover, paclitaxel administration in combination with AdFHIT acts synergistically to increase the apoptotic rate of tumor cells both in vitro and in vivo experiments.